Global Health Ltd — earnings calls

Global Health Limited (Medanta) reported consolidated income of INR13,262 million for Q1 FY27, up 26% year-on-year, with reported EBITDA of INR3,153 million, up 23% year-on-year. Management highlighted a sharp reduction in EBITDA losses at the newly commissioned Medanta Noida facility, from INR236 million in Q4 FY26 to INR49 million in Q1 FY27, alongside strong inpatient and outpatient volume growth across the network. The company also disclosed an expanded and revised Guwahati hospital project, now planned at 650 beds with an estimated cost of approximately INR9,700 million.

Global Health Limited (Medanta) reported Q4 FY26 total income of INR 11,958 million, up 25% year-on-year, with EBITDA excluding Noida growing 27% to INR 3,142 million and margins of 27.5%. For the full year, total income grew 20% to INR 45,089 million and profit after tax rose 15.1% to INR 5,541 million, while the newly launched Noida hospital narrowed its quarterly EBITDA loss to INR 236 million from INR 320 million in Q3. Management outlined an expansion pipeline of roughly 2,700 additional beds through five greenfield projects over the next 3 to 4 years alongside continued capacity additions in existing hospitals.